These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36404953)

  • 1. Identification of potential inhibitors of brain-specific CYP46A1 from phytoconstituents in Indian traditional medicinal plants.
    Kaur K; Devi B; Agrawal V; Kumar R; Sandhir R
    J Proteins Proteom; 2022; 13(4):227-245. PubMed ID: 36404953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP46A1-dependent and independent effects of efavirenz treatment.
    Mast N; El-Darzi N; Petrov AM; Li Y; Pikuleva IA
    Brain Commun; 2020; 2(2):fcaa180. PubMed ID: 33305262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain sterol flux mediated by cytochrome P450 46A1 affects membrane properties and membrane-dependent processes.
    Petrov AM; Mast N; Li Y; Denker J; Pikuleva IA
    Brain Commun; 2020; 2(1):. PubMed ID: 32661514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol Hydroxylating Cytochrome P450 46A1: From Mechanisms of Action to Clinical Applications.
    Pikuleva IA; Cartier N
    Front Aging Neurosci; 2021; 13():696778. PubMed ID: 34305573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Dicaffeoylspermidine Derivatives from Wolfberry as Potent and Selective Inhibitors of Human Cytochrome P450 46A1
    Du J; Liu J; Wang S; Wang C; Meng Q; Sun H; Liu K; Liu Y; Wu J
    Curr Drug Metab; 2023; 24(2):124-130. PubMed ID: 36748817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
    Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
    J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of three naturally occurring lignans, sesamol, sesamolin, and sesamin, as potent inhibitors of human cytochrome P450 46A1: Implications for treating excitatory neurotoxicity.
    Du J; Chen X; Zhao Y; Zhao T; Wang D; Chen Z; Wang C; Meng Q; Yao J; Sun H; Liu K; Wu J
    Front Pharmacol; 2022; 13():1046814. PubMed ID: 36483743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain.
    Mast N; White MA; Bjorkhem I; Johnson EF; Stout CD; Pikuleva IA
    Proc Natl Acad Sci U S A; 2008 Jul; 105(28):9546-51. PubMed ID: 18621681
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Mast N; Anderson KW; Johnson KM; Phan TTN; Guengerich FP; Pikuleva IA
    J Biol Chem; 2017 Aug; 292(31):12934-12946. PubMed ID: 28642370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico and intuitive predictions of CYP46A1 inhibition by marketed drugs with subsequent enzyme crystallization in complex with fluvoxamine.
    Mast N; Linger M; Clark M; Wiseman J; Stout CD; Pikuleva IA
    Mol Pharmacol; 2012 Nov; 82(5):824-34. PubMed ID: 22859721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional and post-translational changes in the brain of mice deficient in cholesterol removal mediated by cytochrome P450 46A1 (CYP46A1).
    Mast N; Lin JB; Anderson KW; Bjorkhem I; Pikuleva IA
    PLoS One; 2017; 12(10):e0187168. PubMed ID: 29073233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases.
    Petrov AM; Pikuleva IA
    Neurotherapeutics; 2019 Jul; 16(3):635-648. PubMed ID: 31001737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis of drug binding to CYP46A1, an enzyme that controls cholesterol turnover in the brain.
    Mast N; Charvet C; Pikuleva IA; Stout CD
    J Biol Chem; 2010 Oct; 285(41):31783-95. PubMed ID: 20667828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of CYP46A1 as a novel therapeutic target for neurological disorders: An updated review of mechanisms.
    Alavi MS; Karimi G; Ghanimi HA; Roohbakhsh A
    Eur J Pharmacol; 2023 Jun; 949():175726. PubMed ID: 37062503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Basis of the Recognition of Cholesterol by Cytochrome P450 46A1 along the Major Access Tunnel.
    Shi N; Zheng Q; Zhang H
    ACS Chem Neurosci; 2022 May; 13(10):1526-1533. PubMed ID: 35438962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of the Allosteric Site in Cholesterol Hydroxylase CYP46A1 for Efavirenz, a Drug That Stimulates Enzyme Activity.
    Anderson KW; Mast N; Hudgens JW; Lin JB; Turko IV; Pikuleva IA
    J Biol Chem; 2016 May; 291(22):11876-86. PubMed ID: 27056331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Activation of Cytochrome P450 46A1 (CYP46A1) by Efavirenz-Related Compounds.
    Mast N; Verwilst P; Wilkey CJ; Guengerich FP; Pikuleva IA
    J Med Chem; 2020 Jun; 63(12):6477-6488. PubMed ID: 31617715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease.
    Djelti F; Braudeau J; Hudry E; Dhenain M; Varin J; Bièche I; Marquer C; Chali F; Ayciriex S; Auzeil N; Alves S; Langui D; Potier MC; Laprevote O; Vidaud M; Duyckaerts C; Miles R; Aubourg P; Cartier N
    Brain; 2015 Aug; 138(Pt 8):2383-98. PubMed ID: 26141492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of a cyano- and fluoro-containing drug bicalutamide to cytochrome P450 46A1: unusual features and spectral response.
    Mast N; Zheng W; Stout CD; Pikuleva IA
    J Biol Chem; 2013 Feb; 288(7):4613-24. PubMed ID: 23288837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal Vascular Abnormalities and Microglia Activation in Mice with Deficiency in Cytochrome P450 46A1-Mediated Cholesterol Removal.
    Saadane A; Mast N; Trichonas G; Chakraborty D; Hammer S; Busik JV; Grant MB; Pikuleva IA
    Am J Pathol; 2019 Feb; 189(2):405-425. PubMed ID: 30448403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.